Ceftriaxone 250gm + Tazobactum 31.25mg - Ceftrial TZ 281.25Ceftrial-TZ 281.25

Dry injectionPacking : 1 VIAL

Composition- Ceftriaxone 250 g + Tazobactam 31.25 mg

MRP : 63.75/-

Prescribed By : Consultant Physician, Surgeon, Intensivist, General Physician

Product Description

Key Benefits of Ceftrial-TZ 281.25

Kills bacteria by collapsing the cell wall, a structure human cells lack
Given intravenously, so full concentration is reached immediately
Restores the antibiotic against organisms that had become resistant to it
Manufactured in a dedicated sterile facility with terminal sterility assurance
Every batch tested for sterility, pyrogens and particulate matter before release

Indications of Ceftrial-TZ 281.25

Serious bacterial infection
Respiratory tract infection
Urinary tract infection
Skin and soft tissue infection
Intra-abdominal infection

How Ceftrial-TZ 281.25 works

This is a combination, and each component has a distinct role. Ceftriaxone blocks the transpeptidase enzymes bacteria use to cross-link their cell wall. Without those cross-links the wall cannot hold internal pressure and the cell bursts. Human cells have no cell wall at all, which is why beta-lactams are among the best-tolerated antibiotics in medicine. Ceftriaxone has an unusually long half-life for a cephalosporin, which is what allows once-daily dosing and makes it practical outside intensive care. Tazobactam has little antibacterial action of its own. Its job is to be attacked. Resistant bacteria defend themselves by producing beta-lactamase enzymes that break the antibiotic's beta-lactam ring; the inhibitor binds those enzymes and occupies them, so the antibiotic passes through intact. That is why the combination works where the antibiotic alone no longer does. Supplying them in one vial means the pair is reconstituted and given together, in the ratio intended.

Why ChooseCeftrial-TZ 281.25?

Manufactured at a WHO-GMP certified facility in a dedicated injectable block, under GLP, ISO and GMP norms. With an injectable the only thing that truly matters is what a patient will not see: sterility, absence of pyrogens, and freedom from particulate matter. Every batch is tested for all three before release, alongside assay and stability. Vials, stoppers and seals are sourced from approved vendors and checked at intake. Offered to PCD franchise partners and to institutional buyers on district-wise monopoly rights, with pan-India supply and complete promotional support.

Frequently asked questions about Ceftrial-TZ 281.25

Is monopoly available for this product?

Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.

What is the composition of Ceftrial-TZ 281.25?

Ceftriaxone 250 g + Tazobactam 31.25 mg.

How is sterility assured?

Manufacturing is carried out in a dedicated injectable block under WHO-GMP norms, and every batch is tested for sterility, pyrogens and particulate matter before it is released.

Do you supply to hospitals and institutions?

Yes. We supply PCD franchise partners as well as hospitals and institutional buyers. Contact our team for rate contracts and supply terms.

What is the minimum order quantity?

Please contact our team for the current MOQ and price structure for your territory.

Last updated on 29 August 2026

This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.